Alzheimer's Vaccine. The second vaccine to be approved is from Oxford University and the pharmaceutical company AstraZeneca. She said the vaccine targets a specific protein known as tau thats commonly found in the brains of Alzheimers patients.
The Food and Drug Administration FDA approval of multiple COVID-19 vaccines brings hope to many especially those living with Alzheimers and dementia and their caregivers who have been critically impacted by the pandemic. For instance some researchers are focused on using a passive immunization technique. The researchers found that the vaccine which targets the beta-amyloid protein was safe and effective in mice.
The same goes for aluminum another horrendously toxic heavy metal that is also a common ingredient in vaccines.
How UB-311 works A peptide is a short stretch of amino acids which are the building blocks of proteins. In people who didnt carry a specific Alzheimers genetic risk factor. UB-311 is composed of amino acids 1-14 in the beta amyloid protein. ACI-35030 is a first-in-class vaccine candidate designed to generate a specific antibody response against pTau proteins in the brain.